Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Massuger

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Gynaecological Oncology|March 5, 2002
Glutathione S-transferases P1-1 and A1-1 in ovarian cyst fluidsE A Boss, W H Peters, H M Roelofs, et al.
Gynecologic Oncology|September 30, 1999
Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature reviewR L Bekkers, W N Willemsen, C P Schijf, et al.
International Journal of Cancer|May 16, 1996
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patientsJ G Tibben, O C Boerman, L F Massuger, et al.
Critical Reviews in Oncology/Hematology|February 18, 2014
BRCA1/2 mutation carriers are potentially at higher cardiovascular riskM Arts-de Jong, A H E M Maas, L F Massuger, et al.
Obstetrics and Gynecology|September 1, 1996
Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The NetherlandsN P Koper, L A Kiemeney, L F Massuger, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysisN P Koper, C M Thomas, L F Massuger, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 1998
Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatographyN P Koper, C M Thomas, L F Massuger, et al.
European Journal of Nuclear Medicine|November 1, 1994
Effect of the route of administration on the biodistribution of radioiodinated OV-TL 3 F(ab')2 in experimental ovarian cancerJ G Tibben, L F Massuger, O C Boerman, et al.
British Journal of Cancer|March 19, 2009
External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic diseaseL G Kerkmeijer, C M Thomas, R Harvey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclideM L Janssen, W Pels, L F Massuger, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Gynaecological Oncology|March 5, 2002
Glutathione S-transferases P1-1 and A1-1 in ovarian cyst fluidsE A Boss, W H Peters, H M Roelofs, et al.
Gynecologic Oncology|September 30, 1999
Leiomyomatosis peritonealis disseminata: does malignant transformation occur? A literature reviewR L Bekkers, W N Willemsen, C P Schijf, et al.
International Journal of Cancer|May 16, 1996
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patientsJ G Tibben, O C Boerman, L F Massuger, et al.
Critical Reviews in Oncology/Hematology|February 18, 2014
BRCA1/2 mutation carriers are potentially at higher cardiovascular riskM Arts-de Jong, A H E M Maas, L F Massuger, et al.
Obstetrics and Gynecology|September 1, 1996
Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The NetherlandsN P Koper, L A Kiemeney, L F Massuger, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysisN P Koper, C M Thomas, L F Massuger, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 1998
Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatographyN P Koper, C M Thomas, L F Massuger, et al.
European Journal of Nuclear Medicine|November 1, 1994
Effect of the route of administration on the biodistribution of radioiodinated OV-TL 3 F(ab')2 in experimental ovarian cancerJ G Tibben, L F Massuger, O C Boerman, et al.
British Journal of Cancer|March 19, 2009
External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic diseaseL G Kerkmeijer, C M Thomas, R Harvey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2003
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclideM L Janssen, W Pels, L F Massuger, et al.
Pageof 6